--- title: "Beginner Steroid Cycle Mistakes: The 10 You Must Avoid" description: "The 10 most common beginner mistakes: doses too high, no PCT, stacking early, no bloods, sketchy sources. Avoid them all." lang: en dateModified: 2026-05-23 canonical: https://anaprotokol.com/en/guides/beginner-steroid-cycle-mistakes --- # Beginner Steroid Cycle Mistakes: The 10 You Must Avoid The **classic mistakes on a first steroid cycle** are almost never subtle technical errors. They are the same handful of decisions, made at the start of the cycle, out of impatience or poor understanding of the mechanisms. This guide walks through them one by one — not to scare anyone, but to make visible what turns a monitored cycle into a long-running problem. Threads on r/steroids, MESO-Rx and T-Nation document the same recurring patterns; the list below is the distilled version. ## Mistake 1 — Doses too high "to get there faster" The gains-to-dose curve is not linear. Most of the gain happens in the lower half of the beginner range; the upper half adds a marginal boost at the cost of side effects that scale linearly (sometimes worse). Doubling the dose does not double the gains, but it unambiguously doubles the rise in hematocrit, aromatization, suppression and blood pressure [1]. The other cost of a starting dose that is too high is the loss of progression room. If the first cycle runs at a high dose, the second one has to climb higher just to 'feel' the difference — that is the escalation that ends up at the forum doses with no link to the minimum effective dose. The beginner range listed on the [testosterone enanthate](/en/molecule/test-enanthate) compound page is deliberately low: it is consistent with the harm-reduction logic of the [first steroid cycle](/en/guides/first-steroid-cycle) pillar. ## Mistake 2 — Stacking multiple compounds on the first cycle A first cycle uses a single compound. Stacking testosterone with an oral, or worse with [nandrolone (Deca)](/en/molecule/nandrolone-deca) or [trenbolone (Tren A)](/en/molecule/trenbolone-acetate), creates a cascade of problems. - If a side effect shows up (acne, gyno tenderness, mood swings, libido tanking), you cannot pin it on a specific compound. The whole read is lost. - Nothing left to explore on the next cycles. If cycle one already combines 3 compounds, the progression room is burned. - Cumulative side effects: testosterone aromatization + nandrolone progestin activity + oral hepatotoxicity stack on terrains you do not always anticipate. The full stacks logic and what they are built for are in the [steroid stacks guide](/en/guides/steroid-stacks-guide) — they have a place, just not on a first cycle. ## Mistake 3 — No PCT or improvised PCT 'I'll figure it out at the end' is the line that comes up most often. At the end of the cycle, either the compounds are not on hand in time, or the protocol is poorly understood, or motivation drops — and PCT gets skipped. Direct consequence: long HPTA recovery, lasting fatigue, meaningful loss of gains, dragged-out low libido, and in the worst cases a post-cycle hypogonadism that can persist for months [3], sometimes years [2]. [PCT](/en/guides/pct-protocol-guide) is planned before the first injection, compounds in hand. The SERM ([Nolvadex](/en/molecule/nolvadex) or [Clomid](/en/molecule/clomid)) is sourced ahead of time, the start date is calculated from the ester half-life, and the post-PCT blood panel is scheduled. > An improvised PCT — wrong SERM, wrong dose, started too early or too late, too short — is often equivalent to no PCT at all. A standard protocol cleanly applied beats an exotic protocol from memory. ## Mistake 4 — No bloods before, during or after Blood work is what turns a cycle from a subjective experience into a monitored process. Without a baseline before the cycle, you cannot know what has moved. Without a mid-cycle panel, you cannot catch hematocrit climbing too high, estradiol running away, or the liver under stress [5]. Without a post-PCT panel, you cannot confirm HPTA recovery. The cost of a blood panel is small compared to the total cycle budget. The [blood work on cycle guide](/en/guides/blood-work-on-cycle) breaks down panels and timing. Three priority markers for a first cycle: hematocrit, estradiol, lipid panel — plus liver markers if orals are in the stack, and a full hormonal panel post-PCT. ## Mistake 5 — Sketchy sources: everything else gets invalidated The black market is saturated with underdosed, mislabelled, or simply not-what-it-says compounds. A cycle built on non-conforming gear does not deliver the expected effects, can deliver other effects (contaminants, different ester), and invalidates the whole blood-work read — you no longer know what you actually injected. - A source that has everything in stock, ships in 48 hours and takes Visa with no fees is almost always a warning sign. - A vial with no batch number, no manufacturing date and no reference is to be discarded. - An answer to 'I feel weird' that is 'increase the dose' rather than 'test your gear' is another red flag. The [gear storage and quality](/en/guides/gear-storage-and-quality) guide covers the signs of bad gear and the use of test kits. A cycle deserves a known, stable source — not an opportunistic plug. ## Mistake 6 — Default-on AI, and other recurring mistakes ### The aromatase inhibitor on autopilot The 2010s default — '0.25 mg anastrozole every other day, just in case' — is over. Estradiol is now understood as necessary for well-being, libido and lipids. Crashing it for no reason creates a new set of problems: dry joints, low libido, depression, trashed lipids. The current approach: measure estradiol on bloods, and only introduce an [aromatase inhibitor](/en/molecule/anastrozole) if values run out of range with clinical signs (breast tenderness, fast water retention, visible puffiness). The [aromatase inhibitors on cycle](/en/guides/aromatase-inhibitors-on-cycle) guide breaks down dosing from bloods. ### Changing the protocol mid-cycle Adding a compound at week 6 'because progress feels slow', bumping the dose mid-cycle, swapping esters: every one of those invalidates the read on effects and bloods. A protocol is set before and held. ### Ignoring blood pressure Blood pressure climbs almost across the board on cycle, especially with water retention and elevated hematocrit. A reliable home cuff, two readings per week, is the simplest way to catch drift early and act before it becomes a cardiovascular issue [4]. ### Treating PCT as the finish line The real debrief happens 3 to 6 months after PCT: what stuck, how you feel, where the blood markers landed. That debrief — not the week-12 mirror shot — tells you what the cycle actually delivered. ## FAQ ### Which of these mistakes is the most dangerous? Hard to rank, but skipping blood work is arguably the one that makes everything else worse. With no baseline and no monitoring, a dose that is too high goes undetected, an estradiol run-up is invisible, severe suppression is unconfirmed, and a default-on AI is never adjusted. It is the mistake that hides the others. ### What do I do if I recognize myself in several of these mistakes mid-cycle? Get a blood panel scheduled as soon as possible — that is what restores visibility. Do not add anything to the protocol, and consider shortening the cycle instead of continuing blind. Rebuild the PCT plan (compounds, doses, timing) if it is not in place. If alarming symptoms show up (chest pain, shortness of breath, visual disturbance), see a doctor without waiting — a cycle is not a subject to carry alone. ### Should I stop a cycle if I messed up the dose or protocol? Not necessarily, but you need to take stock. A mid-cycle blood panel gives you the actual numbers; depending on what it shows, you can lower the dose, shorten the cycle, or continue with tighter monitoring. The decision rests on figures, not on a hunch. And PCT gets prepared either way.